Latest filing published 23 Jun 2026 for Axogen, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of William P. Burke across 4 companies, led by Axogen, Inc., Haemonetics Corp and Miromatrix Medical Inc. In total, 24 filings cover trades dated from 17 May 2021 to 19 June 2026.
The open-market side counts 2 purchases for €108k alongside 8 sales for €388k. Taken together, the sales exceed the purchases by €280k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 7 share grants and 6 option exercises.
The record was last updated on 23 June 2026 with an option exercise in Axogen, Inc. The most recent open-market purchase was published on 25 August 2023, 1,150 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations